Show simple item record

Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?

dc.contributor.authorSikorskii, Alla
dc.contributor.authorGiven, Charles W.
dc.contributor.authorGiven, Barbara A.
dc.contributor.authorVachon, Eric
dc.contributor.authorMarshall, Victoria
dc.contributor.authorKrauss, John C.
dc.contributor.authorBanik, Asish
dc.contributor.authorMajumder, Atreyee
dc.date.accessioned2018-03-07T18:24:23Z
dc.date.available2019-05-13T14:45:24Zen
dc.date.issued2018-03
dc.identifier.citationSikorskii, Alla; Given, Charles W.; Given, Barbara A.; Vachon, Eric; Marshall, Victoria; Krauss, John C.; Banik, Asish; Majumder, Atreyee (2018). "Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?." Psycho‐Oncology 27(3): 1005-1012.
dc.identifier.issn1057-9249
dc.identifier.issn1099-1611
dc.identifier.urihttps://hdl.handle.net/2027.42/142470
dc.description.abstractObjectiveCancer patients, particularly those prescribed with oral oncolytic medications, face treatment side effects and temporary and permanent stoppages of treatment. This research examines how events during treatment affect patients’ beliefs regarding oral oncolytic medications.MethodsA total of 272 cancer patients initiating 1 of 28 oral oncolytic agents were followed for 12 weeks. Assessments of Beliefs About Medications Questionnaire, symptoms, physical function, and depression measures were performed during telephone interviews at intake (medication start) and 4, 8, and 12 weeks. Electronic medical record audits identified dates of temporary and permanent medication stoppages. Linear mixed‐effects models were used for longitudinal analyses of the Beliefs About Medications Questionnaire scores in relation to patient characteristics, symptom severity, and medication stoppages.ResultsOver the initial 12 weeks, beliefs about the necessity of oral medications have increased, concerns have decreased, and interference of medications with daily lives has increased. Permanent stoppage of a medication predicted significant declines in beliefs about its necessity over time. Male patients, those less educated, those reporting higher symptom severity, and those experiencing temporary stoppages had greater concerns. Interference of medications with daily life was higher for males, increased with higher symptom severity, and differed by drug category.ConclusionsPatients’ beliefs in the necessity of their oral medication were affected only by a permanent drug stoppage. Symptom severity, education, and patient sex affected patients’ beliefs about their concerns with their medications and the interference medications posed for their daily lives. Interventions may need to target the distinct dimensions of beliefs during treatment with oral oncolytic agents.
dc.publisherWiley Periodicals, Inc.
dc.subject.othercancer
dc.subject.otherlate stage disease
dc.subject.othermedication beliefs
dc.subject.othermedication stoppages
dc.subject.otheroncology
dc.subject.otheroral oncolytic medications
dc.subject.othersymptoms
dc.titleDo treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142470/1/pon4606.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142470/2/pon4606_am.pdf
dc.identifier.doi10.1002/pon.4606
dc.identifier.sourcePsycho‐Oncology
dc.identifier.citedreferenceTimmers L, Boons CC, Kropff F, et al. Adherence and patients’ experiences with the use of oral anticancer agents. Acta Oncol. 2014; 53 ( 2 ): 259 ‐ 267.
dc.identifier.citedreferenceHorne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47 ( 6 ): 555 ‐ 567.
dc.identifier.citedreferenceHorne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999; 14 ( 1 ): 1 ‐ 24.
dc.identifier.citedreferenceBecker MH. The health belief model and sick role behavior. Health Educ Quart. 1974; 2: 409 ‐ 419.
dc.identifier.citedreferenceJanz NK, Becker MH. The health belief model: a decade later. Health Educ Behav. 1984; 11 ( 1 ): 1 ‐ 47.
dc.identifier.citedreferenceRosenstock IM. Historical origins of the health belief model. Health Educ Quart. 1974; 2: 328 ‐ 335.
dc.identifier.citedreferenceHorne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence‐related beliefs about medicines prescribed for long‐term conditions: a meta‐analytic review of the necessity‐concerns framework. PLoS One. 2013; 8 ( 12 ): e80633
dc.identifier.citedreferenceAndersson Sundell K, Jonsson AK. Beliefs about medicines are strongly associated with medicine‐use patterns among the general population. Int J Clin Pract. 2016; 70 ( 3 ): 277 ‐ 285.
dc.identifier.citedreferenceKumar K, Raza K, Nightingale P, et al. Determinants of adherence to disease modifying anti‐rheumatic drugs in white British and South Asian patients with rheumatoid arthritis: a cross sectional study. BMC Musculoskelet Disord. 2015; 16 ( 1 ): 396
dc.identifier.citedreferenceBhattacharya D, Easthall C, Willoughby KA, Small M, Watson S. Capecitabine non‐adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract. 2012; 18 ( 3 ): 333 ‐ 342.
dc.identifier.citedreferenceTimmers L, Boons CC, Mangnus D, et al. Adherence and patients’ experiences with the use of capecitabine in daily practice. Front Pharmacol. 2016; 7: article 310
dc.identifier.citedreferenceDe las Cuevas C, de Leon J. Reviving research on medication attitudes for improving pharmacotherapy: focusing on adherence. Psychother Psychosom. 2017; 86 ( 2 ): 73 ‐ 79.
dc.identifier.citedreferenceDevlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis. J Manag Care Spec Pharm. 2014; 20 ( 3 ): 309 ‐ 314.
dc.identifier.citedreferenceMichetti P, Weinman J, Mrowietz U, et al. Impact of treatment‐related beliefs on medication adherence in immune‐mediated inflammatory diseases: results of the global ALIGN study. Adv Ther. 2017; 34 ( 1 ): 91 ‐ 108.
dc.identifier.citedreferenceNáfrádi L, Galimberti E, Nakamoto K, Schulz PJ. Intentional and unintentional medication non‐adherence in hypertension: the role of health literacy, empowerment and medication beliefs. J Public Health Res. 2016; 5 ( 3 ): 762
dc.identifier.citedreferenceSalgado TM, Davis EJ, Farris KB, Fawaz S, Batra P, Henry NL. Identifying socio‐demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer. Breast Cancer Res Treat. 2017; 163 ( 2 ): 311 ‐ 319.
dc.identifier.citedreferenceGiven BA, Given CW. Improving adherence to oral cancer agents and self care of symptoms using an IVR. National Cancer Intstitute grant number 1R01CA162401‐01A1. 2013 ‐2017
dc.identifier.citedreferenceHorne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non‐adherence to HAART. Int J STD AIDS. 2004 Jan; 15 ( 1 ): 38 ‐ 44.
dc.identifier.citedreferenceRadloff LS. The CES‐D Scale: a self‐report depression scale for research in the general population. Appl Psychol Measur. 1977; 1 ( 3 ): 385 ‐ 401.
dc.identifier.citedreferenceCella D, Young S, Rothrock N, et al. The patient‐reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007; 45 ( 5 Suppl ): S3 ‐ S11.
dc.identifier.citedreferencePROMIS. Adult physical function profile short forms. 2013. http://assessmentcenter.net Accessed May 1, 2017.
dc.identifier.citedreferenceFoot H, La Caze A, Gujral G, Cottrell N. The necessity‐concerns framework predicts adherence to medication in multiple illness conditions: a meta‐analysis. Patient Educ Couns. 2016; 99 ( 5 ): 706 ‐ 717.
dc.identifier.citedreferenceDe Smedt RH, Denig P, van der Meer K, Haaijer‐Ruskamp FM, Jaarsma T. Self‐reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: a cross‐sectional survey. Int J Nurs Stud. 2011; 48 ( 12 ): 1540 ‐ 1550.
dc.identifier.citedreferenceGrassi L, Meggiolaro E, Berardi MA, et al. Beliefs about medicines, doctor‐patient relationship, and coping among European patients with cancer. Psycho‐Oncol. 2017; 26 ( 2 ): 282 ‐ 285.
dc.identifier.citedreferenceAikens JE, Piette JD. Diabetic patients’ medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009; 32 ( 1 ): 19 ‐ 24.
dc.identifier.citedreferenceFederman AD, Wolf M, Sofianou A, et al. The association of health literacy with illness and medication beliefs among older adults with asthma. Patient Educ Couns. 2013; 92 ( 2 ): 273 ‐ 278.
dc.identifier.citedreferenceWeingart SN, Brown E, Bach PB, et al. NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw. 2008; 6 ( 3 ): S1 ‐ S16.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.